See more Clinical Trials

Osimertinib improves overall survival in untreated EGFR-mutated advanced non-small cell lung cancer

Mature results of the FLAURA trial

12/21/2019 19:37 0 COMENTÁRIOS

Advances sustained by molecular classification in a universe of unknown possibilities

07/28/2019 20:06 1 COMENTÁRIOS

Benefits sustained only on surrogate endpoints

07/21/2019 18:45 1 COMENTÁRIOS

Therapeutic options and toxicity profile

06/26/2019 19:16 0 COMENTÁRIOS